Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: WDI Publishing, William Davidson Institute (EDI), University of Michigan
Originally published in: 2010
Version: 6 January 2010
Length: 8 pages
Data source: Published sources
Topics: Strategy

Abstract

This case details the history of Zantac, one of Glaxo's most successful products, from inception to deterioration when faced by the rise of generics. In doing so, the mini-case describes the main players, trends and obstacles dominating the pharmaceutical industry today. This case is included in Module 1 of the course Business Thought & Action.

About

Abstract

This case details the history of Zantac, one of Glaxo's most successful products, from inception to deterioration when faced by the rise of generics. In doing so, the mini-case describes the main players, trends and obstacles dominating the pharmaceutical industry today. This case is included in Module 1 of the course Business Thought & Action.

Related